GSK’s shingles vaccine scores US approval
October 23, 2017Sales and Marketing FDA, GSK, Shingrix, pharma, shingles
GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention …
MSD cuts 1,800 jobs in US operations restructure
October 23, 2017Manufacturing and Production, Sales and Marketing MSD, Merck, job cuts, pharma
MSD has revealed its intention to cut 1,800 sales positions from its workforce in the US. Across the total number, …
$417 million case against J&J thrown out
October 23, 2017Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical, talc
A judge in California has thrown out the lawsuit made by a woman who had alleged that Johnson & Johnson’s …
Report reveals impact of pollution, with 9m deaths worldwide
October 20, 2017Medical Communications biotech, drugs, pharma, pharmaceutical, pollution
A new report published in The Lancet has revealed that all forms of pollution are linked with 9 million deaths …
Top Ten most popular articles on Pharmafile.com this week
October 20, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Another week gone, and it’s deadline day here at Pharmafocus, meaning you can look forward to our November issue next …
Small number of mutations driving most cancers
October 20, 2017Medical Communications, Research and Development Cancer, biotech, drugs, pharma, pharmaceutical
Research from scientists at the Wellcome Trust Sanger Institute has found that only between one and 10 genetic mutations are …
Teva under investigation over illegal rebate offers to Ontario pharmacies
October 20, 2017Medical Communications, Sales and Marketing Teva, fentanyl, opioids, oxycodone
Israeli drugmaker Teva has again become embroiled in a scandal investigated by the Ontario government for allegedly bribing pharmacies to …
Celgene drops $710m drug, shares nosedive 7%
October 20, 2017Medical Communications, Research and Development Celgene, biotech, drugs, pharma, pharmaceutical
Celgene took a gamble when it spent $710 million up-front on an inflammatory disorder treatment, but it now looks likely …
Worrying number of organ donations blocked by families
October 19, 2017Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical
A report from the BBC has found that 505 registered organ donors had their decision blocked by relatives, over the …
Access to Innovation: Beyond a ‘pharma-only’ approach
October 19, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ecco, oncology
Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …
Lilly teams up with CureVac in $1.8 billion cancer vaccine partnership
October 19, 2017Research and Development, Sales and Marketing Cancer, CureVac, Eli Lilly, Vaccine
Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to …
Vir Biotech blasts out of the blocks, with $500m in bank
October 19, 2017Medical Communications, Sales and Marketing Vir Biotechnology, biotech, drugs, pharma, pharmaceutical
All has been quiet since former Biogen CEO, George Scangos, departed the company and then set up Vir Biotechnology in …
Novo’s diabetes treatment semaglutide gets unanimous FDA backing
October 19, 2017Sales and Marketing Novo Nordisk, diabetes, semaglutide
Novo Nordisk is celebrating the news that its diabetes drug semaglutide has won the favour of FDA experts, with one …
Gilead gets FDA nod for revolutionary blood cancer treatment
October 19, 2017Sales and Marketing CAR-T, Gilead, Yescarta, biotech, drugs, pharma, pharmaceutical
Only weeks after Gilead announced the completion of Kite, it got the news it was hoping for with the FDA’s …
First-ever study in the personalised treatment of rare cancers brings promising results
October 18, 2017Research and Development Cancer, Cancer Research UK, personalised medicine, pharma, rare cancer
The first-ever trial to treat patients for rare cancers in a personalised manner based on the characteristics of their individual …
Breakthrough AI able to identify 97% of breast cancer risk
October 18, 2017Research and Development MIT, biotech, breast cancer, drugs, pharma, pharmaceutical
Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that is able diagnose …
Novartis sheds generics plant and 450 jobs amid pricing pressure
October 18, 2017Manufacturing and Production, Research and Development Novartis, US, closure, generics, manufacturing, pharma
Novartis has announced its intention to shut down its US generics manufacturing plant in Broomfield, Colorado, a move that will …
New studies point to cracks forming in NHS services
October 18, 2017Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical
Two studies published separately by the BBC and the Care Quality Commission (CQC) point to growing problems across NHS services …
J&J’s third quarter: The good and the bad
October 18, 2017Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Janssen, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical
It was a mixed bag for Johnson & Johnson on its announcement of third quarter results. It could largely be …
Allergan’s patent shield – The (Native) American dream?
October 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical
In an unprecedented move, leading global pharmaceutical company Allergan appears to have handed its Orange Book-listed US patents covering …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
